Molten Ventures VCT plc
LEI: 2138003I9Q1QPDSQ9Z97
Half-Year Results
For
the six months ended 31 December 2024
RECENT PERFORMANCE SUMMARY
|
30
September
2024
|
31
March
2024
|
30
September
2023
|
|
pence
|
pence
|
pence
|
Net asset value per share
("NAV")
|
43.2
|
48.2
|
49.9
|
Cumulative dividends paid since
launch
|
117.6
|
115.1
|
115.1
|
Total Return (NAV plus cumulative
dividends paid per share)
|
160.8
|
163.3
|
165.0
|
|
|
|
|
DIVIDENDS
Recent
|
Amount per share
|
Date of payment
|
Ex-div date
|
Record date
|
2024 Interim
|
1.0p
|
5 April 2024
|
22 February 2024
|
23 February 2024
|
2024 Final
|
1.5p
|
26 September
2024
|
22 August 2024
|
23 August 2024
|
A full dividend history for the
Company can be found at investors.moltenventures.com/investor-relations/vct
CHAIRMAN'S STATEMENT
I am pleased to present the
Half-Yearly Report for the Company for the six months ended 30
September 2024.
I would like to welcome Shareholders
who joined us as a result of the recent offers for subscription and
express our gratitude to both new and the existing Shareholders who
continue to support the Company despite the difficult markets we
continue to face.
Despite market conditions for deals
remaining difficult, we have seen a steady level of new investment
activity, utilising some of the funds raised from the successful
offer for subscription earlier this year. It is our view that the
market is improving but cyclical.
Net
Asset Value and results
At 30 September 2024, the Company's
Net Asset Value per share ("NAV") stood at 43.2p, a decrease of
2.5p since 31 March 2024 (after adding back the dividends paid
during the period).
The loss on ordinary activities
after taxation for the period was £6.9 million, comprising a
revenue gain of £276,000 and a capital loss, arising almost
entirely on 30 September 2024 valuations, of £7.2
million.
Dividends
In 2024, the Company paid dividends
totalling 2.5p in April and September. As explained in the 2024
Annual Report, VCT regulations limit dividend payments from
reserves associated with funds raised in the last three to four
years. Following several successful fundraisings, the Board must
manage reserves carefully to ensure compliance with these
regulations.
While the Board targets annual
dividends of 5% of net asset value, due to a lack of available
reserves for the accounting period ending 31 March 2025 no further
dividends are proposed for this period. Significant additional
reserves will become available after 1 April 2025 and the Board
remains committed to its dividend policy and intends to resume
dividend payments once reserves are accessible under the VCT
rules.
Shareholders are reminded that the
Company operates a Dividend Reinvestment Scheme, which allows
Shareholders to reinvest their dividends automatically into new
shares in the Company and obtain further income tax relief on that
investment. Further details about how to opt-in can be found in the
"Shareholder Information" section on page 3 of the Half Yearly
report.
Venture capital investments
During the period, the Company made
3 new and 1 follow-on investments, at a total cost of £3.3
million.
New investments were made in Dines
App Limited, FintechOS Holding B.V. and XMOS Limited. A follow-on
investment was made in Global Satellite Vu Limited.
At the period end, the Company held
a portfolio of 48 venture capital investments, valued at £75.6
million, a loan note valued at £0.5 million, and held net cash for
investment of £38.2 million.
As usual, the Board has reviewed the
valuations of the unquoted investments as at 30 September 2024 and
a number of adjustments to their carrying values have been made.
This has resulted in a net valuation downturn of £6.2 million for
the period across the whole portfolio.
The Company holds an AIM-quoted
investment, Pulsar plc valued at its share price as at 30 September
2024 which saw a increase of £0.4 million over the period and was
valued at £4.6 million.
Fundraising
As noted in the last Annual Report,
the Company launched another successful offer for subscription in
October 2023 which closed in August 2024 having raised £15.7
million net of costs.
In October 2024, the Company
continued its practice of a new offer and launched a limited
subscription for new shares.
Shareholders can find full details
of the offer, including the prospectus, and online application
at:
investors.moltenventures.com/investor-relations/vct
Investors are recommended to consult
their financial adviser before making any investment
decisions.
Share buybacks
The Company continues to operate a
policy of buying in its shares that become available in the market
at approximately a 5% discount to the latest published NAV, subject
to regulatory and liquidity constraints.
In line with this policy, during the
period, the Company purchased 1,047,051 shares for cancellation at
an average price of 44.91p per share.
As noted above in respect of the
dividend, the Board is currently monitoring the Company's
distributable reserves to ensure continued compliance with the VCT
regulations, and it is not expected that any further share buybacks
will be made prior to the end of March 2025. However, the Board
confidently expects to resume buybacks, subject to the above, from
1 April 2025 onwards.
Any Shareholders considering selling
their shares will need to use a stockbroker, whom you should ask to
contact Panmure Liberum Limited, who acts as the Company's
corporate broker, and maintains a list of potential sellers to be
contacted when the next buyback is undertaken by the
Company.
Outlook
Although we have seen a fall in NAV
over the period, the Board is satisfied with the approach taken by
the manager in supporting existing portfolio companies, working on
realisations and continuing to identify suitable new
opportunities.
We are hopeful that conditions will
begin to improve in 2025 and that we may now be approaching a point
in the cycle when excellent investment opportunities in the sectors
in which your Company operates are available at attractive prices
which can drive strong performance in future.
I look forward to updating
Shareholders on progress in my statement in the Annual Report to 31
March 2025, which will be published in the summer.
David Brock
Chairman
11
December 2024
INVESTMENT MANAGER'S REPORT
The backdrop for technology
companies and those who invest in them remains mixed with a number
of portfolio companies performing well and some challenges which
have constrained the overall VCT portfolio performance.
Our focus within this context has
been on what we can control. We have maintained discipline around
our own investment process and worked closely with our portfolio
companies to extend cash runways, control costs, and retain talent.
The entrepreneurs we have backed continue to transform the
industries in which they operate.
The valuation movements in the first
half of the year showed a NAV Total Return decrease of 5.2% (NAVTR
- adding back dividends paid in the period).
In the period 2.5p of dividends were
paid equivalent to just over a 5% yield on the starting year NAV of
48.2p (31 March 2024). This is a welcome return to meeting the VCTs
target 5% annual yield.
In the period three new investments
were made totalling £2.7 million and one follow-on investment of
£0.6 million. One portfolio exit was achieved as outlined
below.
Exit Highlight
Endomagnetics Ltd ('Endomag')
returned £8.3 million to the VCT a multiple of 3.9x
cost.
In July we were delighted that
portfolio company Endomag was acquired by NASDAQ listed Hologic
Inc. The acquisition valued Endomag at approximately $310 million.
There is the potential of further escrow proceeds of c. £0.8
million.
The VCT first invested in Endomag in
2018 and since then the company has grown its revenue fourfold. The
acquisition demonstrates our ability to support innovative
businesses as they scale and create value for our Shareholders
through the cycle. Endomag's platform has been installed in over
1,350 hospitals in over 45 countries globally, and more than
500,000 women have received a better standard of breast cancer
surgery with Endomag's technologies. The Company received many
accolades on its journey and more recently was awarded the King's
Award for Enterprise.
To assist with its future wider
portfolio exit strategy Molten has a relationship with a leading
investment bank advising international technology and climate
companies, developing and executing growth financings and strategic
sell-side M&A. Its CEO is well known to the Molten team having
worked on many exits with Molten partners in the past.
Portfolio
At the period end, Molten technology
companies represented 53.6% of the portfolio and pre-Molten legacy
companies 13.0%. The net asset valuation of £118.9 million was
split 67.9% in investments, and 32.1% in cash and cash
equivalents.
Molten Ventures takes an active role
in building businesses and typically has board representation on
investee companies as a director or observer.
Valuation movements
Within the period 10 companies had
positive valuation uplifts totalling £6.7 million and 14 companies
had negative valuation movements totalling £12.9
million.
Positive meaningful movements
(movements above £0.25 million) within the portfolio include
Riverlane, Melio Healthcare, Freetrade and Pulsar Group.
Riverlane is the largest uplift
where a major new investment round of $75 million increased the
valuation by £3.9 million. This $75 million in Series C funding
will allow Riverlane to deliver its groundbreaking quantum error
correction (QEC) roadmap, and to expand operations to meet surging
global market demand for QEC technology, with the goal of achieving
one million error- free quantum computer operations by
2026.
Post the period end proceeds of £0.3
million were received from the sale of Hampshire Sport and Leisure,
a legacy portfolio company, that was previously valued at
nil.
Valuation reductions have been
recorded in some companies with sound prospects where market
valuation multiples have declined. This includes Thought Machine
where the valuation declined by £3.8 million as market multiples
have fallen; and Macranet, a legacy business where a new investment
round has subordinated the VCT returns position where the VCT was
unable to invest due to the non-qualifying nature of the business.
The valuation has been reduced by £0.9 million.
Another company in this category is
IESO where a further provision of £0.9 million was taken. Here the
technology build and commercial roll out has taken longer than
expected. While disappointing, the revenue potential from IESO's
technology is very large and if the company can commercialise its
new AI- enabled digital mental health platform it could prove to be
a very valuable technology. There is scope from this for the value
of the holding to increase again in the future. The encouraging
news was a very successful clinical trial that completed on the new
digital product and demonstrated performance on a par with human
therapists. IESO's other service-based business, utilising its
unique database, grew its revenue in the year from single digit to
double digit millions.
Regrettably there have been a number
of other write-downs including:
Evonetix (write down of £1.3
million) and Gardin (write down of £1.3 million). These deep tech
companies are both struggling to find commercial market fit.
Morressier (write down of £3.2 million) has failed to convert its
projected customer pipeline into realised revenues; and Allplants
(write down of £0.8 million) has entered into administration
post-period end.
New
investments
New investments alongside the Molten
EIS and Molten Ventures plc funds were made during the period into
the following qualifying companies:
XMOS Limited
|
|
IOT semiconductor
designer
|
£888,704
|
FintechOS Holding B.V.
|
|
Banking application
software
|
£1,493,874
|
Dines App Limited
|
|
Hospitality point of sales
solutions
|
£300,000
|
Total
|
£2,682,578
|
Deal Flow
At the time of publication, five
further new investments and three follow-on investments have
completed post the period end.
Outlook
The aggregate portfolio performance
in first half of the year has been disappointing however we
maintain the belief that investing in cutting edge technology
companies can yield returns over the long term. The exit of VCT
company Endomag is a good example of this.
We are actively working on a
pipeline of further exits and expect to be able to report on
successful, profitable outcomes as transactions
complete.
With the ongoing expectation of a
more normalised realisations market, we remain cautiously
optimistic for the portfolio as the technology markets continue to
stabilise.
Elderstreet Investments Limited
Part of the Molten Ventures Group
11
December 2024
SUMMARY OF INVESTMENT PORTFOLIO
Portfolio of investments
The following investments were held
at 30 September 2024. All companies are registered in England and
Wales, with the exception of Fulcrum Utility Services Limited,
which is registered in the Cayman Islands, and Anima, which is
incorporated in Delaware with a UK establishment.
|
|
|
|
|
|
Cost
£'000
|
Valuation
£'000
|
Valuation
movement
in period
£'000
|
% of
portfolio
by value
|
Top
ten venture capital investments (by value)
|
|
|
|
|
Riverlane Limited *
|
2,661
|
8,030
|
3,916
|
6.8
|
Form3 UK Limited (formerly Back
Office Technology Ltd) *
|
1,420
|
7,981
|
25
|
6.7
|
Fords Packaging Topco Limited
*
|
2,433
|
7,101
|
-
|
6.0
|
Focal Point Positioning Limited
*
|
3,800
|
6,150
|
(268)
|
5.2
|
Thought Machine Group Limited
*
|
2,400
|
5,928
|
(3,760)
|
5.0
|
Global Satellite Vu Limited
*
|
4,689
|
4,689
|
(290)
|
3.9
|
Pulsar plc (formerly Access
Intelligence plc) **
|
2,586
|
4,571
|
415
|
3.8
|
Melio Healthcare Limited *
|
2,520
|
3,283
|
763
|
2.8
|
Expanding Circle Limited *
|
2,931
|
2,931
|
-
|
2.5
|
Anima Group Inc *
|
2,653
|
2,653
|
-
|
2.2
|
|
28,093
|
53,317
|
801
|
44.9
|
Other venture capital investments
|
50,162
|
27,374
|
(13,167)
|
23.0
|
|
|
|
|
|
Cash
and cash equivalents
|
38,169
|
38,169
|
-
|
32.1
|
|
|
|
|
|
Total investments
|
116,424
|
118,860
|
(12,366)
|
100.0
|
All venture capital investments are
unquoted unless otherwise stated.
* These
companies have also received investment from other funds managed by
the Molten Ventures Group (Molten Ventures plc and
Molten Ventures EIS funds) as at 30 September
2024.
**Quoted on
AIM
INVESTMENT MOVEMENTS FOR THE SIX MONTHS ENDED 30
SEPTEMBER 2024
Additions
|
|
|
|
|
|
Venture capital investments
|
£'000
|
|
FintechOS Holdings B.V
*
|
1,494
|
|
XMOS Limited *
|
889
|
|
Global Satellite Vu Limited
*
|
600
|
|
Dines App Limited *
|
300
|
|
|
3,283
|
|
Disposals
|
|
|
|
|
Value at
|
|
|
|
Cost
|
1 April
2024
|
Proceeds
|
Gain
vs cost
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Venture capital investments
|
|
|
|
|
Endomagnetics Limited
*
|
2,147
|
8,819
|
8,305
|
6,158
|
|
2,147
|
8,819
|
8,305
|
6,158
|
|
|
|
|
|
|
|
This investment was revalued over
time and until sold, with any unrealised gain included in the fair
value of investments.
*These companies have also received
investment from other funds managed by the Molten Ventures Group
(Molten Ventures plc and Molten Ventures EIS funds) as at 30
September 2024.
UNAUDITED INCOME STATEMENT
for the six months ended 30
September 2024
|
Six months
ended
30 September
2024
(unaudited)
|
Six
months ended
30
September 2023
(unaudited)
|
Year
ended
31 March
2024
(audited)
|
|
Revenue
|
Capital
|
Total
|
Revenue
|
Capital
|
Total
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
|
908
|
-
|
908
|
348
|
-
|
348
|
980
|
Gains/(losses) on
investments
|
|
|
|
|
|
|
|
Realised
|
-
|
6,158
|
6,158
|
-
|
-
|
-
|
(4,523)
|
Unrealised
|
-
|
(12,366)
|
(12,366)
|
-
|
(2,611)
|
(2,611)
|
(1,460)
|
|
908
|
(6,208)
|
(5,300)
|
348
|
(2,611)
|
(2,263)
|
(5,003)
|
|
|
|
|
|
|
|
|
Investment management
fees
|
(319)
|
(958)
|
(1,277)
|
(324)
|
(973)
|
(1,297)
|
(2,537)
|
Other expenses
|
(313)
|
-
|
(313)
|
(233)
|
-
|
(233)
|
(514)
|
|
|
|
|
|
|
|
|
Gain/(loss) on ordinary
activities before
tax
|
276
|
(7,166)
|
(6,890)
|
(209)
|
(3,584)
|
(3,793)
|
(8,054)
|
|
|
|
|
|
|
|
|
Tax on gain/(loss)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
Gain/(loss) attributable to equity Shareholders being total
comprehensive income for the period
|
276
|
(7,166)
|
(6,890)
|
(209)
|
(3,584)
|
(3,793)
|
(8,054)
|
|
|
|
|
|
|
|
|
|
Pence
|
Pence
|
Pence
|
Pence
|
Pence
|
Pence
|
Pence
|
Basic and diluted return
per
share
|
0.1
|
(2.6)
|
(2.5)
|
(0.1)
|
(1.6)
|
(1.7)
|
(3.3)
|
All Revenue and Capital items in the
above statement are derived from continuing operations. No
operations were acquired or discontinued during the
period.
UNAUDITED BALANCE SHEET
as at 30 September 2024
|
30
September
2024
|
|
30
September
2023
|
|
31
March
2024
|
|
(unaudited)
|
|
(unaudited)
|
|
(audited)
|
|
£'000
|
|
£'000
|
|
£'000
|
Fixed assets
|
|
|
|
|
|
Investments
|
80,691
|
|
92,168
|
|
91,921
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
Debtors
|
167
|
|
143
|
|
213
|
Cash at bank and in hand
|
316
|
|
2,885
|
|
3,226
|
Money market fund
investments
|
37,853
|
|
26,219
|
|
21,876
|
|
38,336
|
|
29,247
|
|
25,315
|
|
|
|
|
|
|
Creditors: amounts falling
due
within one year
|
(158)
|
|
(101)
|
|
(182)
|
|
|
|
|
|
|
Net
current assets
|
38,178
|
|
29,146
|
|
25,133
|
|
|
|
|
|
|
Net
assets
|
118,869
|
|
121,314
|
|
117,054
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
Called up share capital
|
13,758
|
|
12,146
|
|
12,146
|
Capital redemption
reserve
|
114
|
|
62
|
|
62
|
Share premium account
|
39,572
|
|
25,510
|
|
25,510
|
Special reserve
|
54,211
|
|
63,602
|
|
62,190
|
Capital reserve -
unrealised
|
13,520
|
|
24,735
|
|
25,886
|
Capital reserve -
realised
|
(313)
|
|
(2,431)
|
|
(6,471)
|
Revenue reserve
|
(1,993)
|
|
(2,310)
|
|
(2,269)
|
|
|
|
|
|
|
Total equity shareholders' funds
|
118,869
|
|
121,314
|
|
117,054
|
|
|
|
|
|
|
|
Pence
|
|
Pence
|
|
Pence
|
Basic and diluted net asset value per share
|
43.2
|
|
49.9
|
|
48.2
|
UNAUDITED STATEMENT OF CHANGES IN EQUITY
for the six months ended 30
September 2024
|
Share
capital
|
Capital
redemption
reserve
|
Share
premium
account
|
Special
reserve
|
Capital
reserve-
unrealised
|
Capital
reserve-
realised
|
Revenue
reserve
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
At 1
April 2023
|
10,347
|
-
|
8,689
|
65,178
|
27,346
|
853
|
(2,101)
|
110,312
|
Total comprehensive
income
|
-
|
-
|
-
|
-
|
(5,529)
|
(2,357)
|
(168)
|
(8,054)
|
Transfer between reserves
|
-
|
-
|
-
|
(2,385)
|
4,069
|
(1,684)
|
-
|
-
|
Transactions with owners
|
|
|
|
|
|
|
|
|
Issue of new shares
|
1,861
|
-
|
17,837
|
-
|
-
|
-
|
-
|
19,698
|
Share issue costs
|
-
|
-
|
(1,016)
|
-
|
-
|
-
|
-
|
(1,016)
|
Purchase of own shares
|
(62)
|
62
|
-
|
(603)
|
-
|
-
|
-
|
(603)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(3,283)
|
-
|
(3,283)
|
At
31 March 2024
|
12,146
|
62
|
25,510
|
62,190
|
25,886
|
(6,471)
|
(2,269)
|
117,054
|
Total comprehensive income
|
-
|
-
|
-
|
-
|
(12,366)
|
5,200
|
276
|
(6,890)
|
Transfer between reserves *
|
-
|
-
|
-
|
(958)
|
-
|
958
|
-
|
-
|
Transactions with owners
|
|
|
|
|
|
|
|
|
Issue of new shares
|
1,664
|
-
|
14,659
|
-
|
-
|
-
|
-
|
16,323
|
Share issue costs
|
-
|
-
|
(597)
|
-
|
-
|
-
|
-
|
(597)
|
Purchase of own shares
|
(52)
|
52
|
-
|
(473)
|
-
|
-
|
-
|
(473)
|
Dividends paid
|
-
|
-
|
-
|
(6,548)
|
-
|
-
|
-
|
(6,548)
|
At
30 September 2024
|
13,758
|
114
|
39,572
|
54,211
|
13,520
|
(313)
|
(1,993)
|
118,869
|
* A transfer of £1.0 million,
representing realised losses on investment disposals plus capital
expenses in the period, has been made from Capital Reserve -
realised to the Special reserve.
UNAUDITED STATEMENT OF CASH FLOWS
for the six months ended 30
September 2024
|
Six months
ended
30
September
2024
|
Six
months
ended
30
September
2023
|
Year
ended
31
March
2024
|
|
(unaudited)
|
(unaudited)
|
(audited)
|
|
£'000
|
£'000
|
£'000
|
Cash flow from
operating activities |
|
|
|
Investment income
received
|
857
|
220
|
876
|
Investment management fees
paid
|
(1,304)
|
(1,308)
|
(2,554)
|
Other cash payments
|
(290)
|
(223)
|
(463)
|
Net
cash outflow utilised in operating activities
|
(737)
|
(1,311)
|
(2,141)
|
|
|
|
|
Cash flow from investing
activities
|
|
|
|
Purchase of investments
|
(3,283)
|
(13,223)
|
(16,376)
|
Sale of investments
|
8,305
|
-
|
29
|
Net
cash inflow generated from/(outflow utilised in) investing
activities
|
5,022
|
(13,223)
|
(16,347)
|
|
|
|
|
Cash flow from financing
activities
|
|
|
|
Equity dividends paid
|
(6,133)
|
(3,284)
|
(3,098)
|
Proceeds from share issue
|
15,909
|
19,699
|
19,513
|
Share issue costs
|
(521)
|
(1,019)
|
(1,067)
|
Purchase of own shares
|
(473)
|
(603)
|
(603)
|
Net
cash inflow generated from financing activities
|
8,782
|
14,793
|
14,745
|
|
|
|
|
Increase/(decrease) in cash and cash
equivalents
|
13,067
|
259
|
(3,743)
|
Cash and cash equivalents at start
of period
|
25,102
|
28,845
|
28,845
|
Cash and cash equivalents at end of
period
|
38,169
|
29,104
|
25,102
|
|
|
|
|
Total cash and cash equivalents
|
38,169
|
29,104
|
25,102
|
|
|
|
|
Cash and cash equivalents comprise of:
|
|
|
|
Cash at bank
|
316
|
2,885
|
3,226
|
Money market funds
|
37,853
|
26,219
|
21,876
|
|
38,169
|
29,104
|
25,102
|
|
|
|
|
NOTES TO THE UNAUDITED FINANCIAL
STATEMENTS
for the six months ended 30
September 2024
1. The unaudited
Half-Yearly Report covers the six months to 30 September 2024 and
has been prepared in accordance with the accounting policies set
out in the statutory accounts for the period ended 31 March 2024,
which were prepared in accordance with the Financial Reporting
Standard 102 ("FRS 102") and the Statement of Recommended Practice
"Financial Statements of Investment Trust Companies" issued in July
2022 ("SORP").
2. The Company has
only one class of business and derives its income from investments
made in shares, securities and money market funds.
3. The comparative
figures are in respect of the six months ended 30 September 2023
and the year ended 31 March 2024, respectively.
4. Basic and diluted return per
share
|
Six months
ended
30
September
2024
|
Six
months
ended
30
September
2023
|
Year
ended
31
March
2024
|
|
(unaudited)
|
(unaudited)
|
(audited)
|
Basic and diluted loss per share (pence)
|
(2.5)
|
(1.7)
|
(3.3)
|
|
|
|
|
Return per share based
on:
|
|
|
|
Net revenue gain/(loss) for the
period (£'000)
|
276
|
(209)
|
(168)
|
Net capital loss for the period
(£'000)
|
(7,166)
|
(3,584)
|
(7,886)
|
Total losses for the period
(£'000)
|
(6,890)
|
(3,793)
|
(8,054)
|
|
|
|
|
Weighted average number of shares in
issue
|
270,395,470
|
224,828,251
|
242,863,047
|
As the Company has not issued any
convertible securities or share options, there is no dilutive
effect on return per share. The return per share disclosed,
therefore, represents both basic and diluted return per
share.
5. Dividends
|
|
Six months
ended
30
September
2024
(unaudited)
|
|
Year
ended
31
March
2024
(audited)
|
|
|
Revenue
|
Capital
|
Total
|
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
|
£'000
|
Dividends paid in the period
|
|
|
|
|
|
|
2024 Final (Paid 26 September
2024)
|
1.5p
|
-
|
4,119
|
4,119
|
|
-
|
2024 Interim (Paid 5 April
2024)
|
1.0p
|
-
|
2,429
|
2,429
|
|
-
|
2023 Final (Paid 29 September 2023)
|
0.5p
|
-
|
-
|
-
|
|
1,214
|
2023 Interim (Paid 6 April
2023)
|
1.0p
|
-
|
-
|
-
|
|
2,069
|
|
|
-
|
6,548
|
6,548
|
|
3,283
|
Including £415,000 of
DRIS allotments
6. Basic and diluted net asset value per
share
|
At
30 September
2024
|
|
At
30
September
2023
|
|
At
31
March
2024
|
|
(unaudited)
|
|
(unaudited)
|
|
(audited)
|
Net
asset value per share based on:
|
|
|
|
|
|
Net assets (£'000)
|
118,869
|
|
121,314
|
|
117,054
|
|
|
|
|
|
|
Number of shares in issue at period
end
|
275,165,959
|
|
242,913,196
|
|
242,913,196
|
|
|
|
|
|
|
Net asset value per share
(pence)
|
43.2
|
|
49.9
|
|
48.2
|
7. Called up share capital
|
At
30 September
2024
|
|
At
30
September
2023
|
|
At
31
March
2024
|
Ordinary Shares of 5p each
|
|
|
|
|
|
Number of shares in issue at period
end
|
275,165,959
|
|
242,913,196
|
|
242,913,196
|
|
|
|
|
|
|
Nominal value (£'000)
|
13,758
|
|
12,146
|
|
12,146
|
During the period the Company issued
a total of 32,427,788 Ordinary Shares of 5p each ("Ordinary
Shares") at an average price of 49.06p per share, under the offer
that launched in October 2023. The gross proceeds of the Offer were
£15.9 million, with issue costs in respect of the Offer amounting
to £0.6 million.
Following the payment of a dividend
on 5 April 2024, 300,379 Ordinary Shares at an average price of
47.27p were allotted under the Dividend Reinvestment Scheme
("DRIS"). The amount re-invested totalled £142,000.
Following the payment of a dividend
on 26 September 2024, 571,647 Ordinary Shares at an average price
of 47.71p were allotted under the DRIS. The amount re-invested
totalled £273,000.
During the period, the Company
purchased 1,047,051 Ordinary Shares for cancellation for an
aggregate consideration of £473,000, equating to an average price
of 44.91p per share (approximately equal to a 5% discount to the
most recently published NAV at the time of purchase) and
representing 0.4% of the issued share capital in issue at 31 March
2024.
8. Reserves
Distributable reserves are
calculated as follows:
|
30
September
|
30
September
|
31
March
|
|
2024
|
2023
|
2024
|
|
(unaudited)
|
(unaudited)
|
(audited)
|
|
£'000
|
£'000
|
£'000
|
Special reserve
|
54,211
|
63,602
|
62,190
|
Special reserve - restricted amounts
transferred from share premium *
|
(43,407)
|
(54,886)
|
(54,886)
|
Capital reserve -
realised
|
(313)
|
(2,431)
|
(6,471)
|
Revenue reserve
|
(1,993)
|
(2,310)
|
(2,269)
|
Capital reserve - unrealised:
excluding unrealised unquoted gains
|
(13,219)
|
(6,149)
|
(5,387)
|
|
(4,721)
|
(2,174)
|
(6,823)
|
*The Special Reserve was created
following the cancellation of the Share Premium Account. The VCT
regulations restrict the distribution of this Special Reserve until
a date at least three years after the year end in which the funds
were originally raised. On 1 April 2023 £6.2 million of the Special
Reserve became unrestricted and on 1 April 2024 a further £11.5
million became unrestricted. A further £36.0 million of the Special
Reserve will become unrestricted on 1 April 2025.
9. Investments
The fair value of investments is
determined using the detailed accounting policy as set out in Note
1 of the Annual Report.
The Company has categorised its
financial instruments using the fair value hierarchy as
follows:
Level 1 Reflects
financial instruments quoted in an active market (fixed interest
investments, and investments in shares quoted on either the Main
Market or AIM);
Level 2 Reflects
financial instruments that have prices that are observable either
directly or indirectly; and
Level 3 Reflects
financial instruments that use valuation techniques that are not
based on observable market data (unquoted equity investments and
loan note investments).
|
30 September
2024
|
30
September 2023
|
31 March
2024
|
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|
Level
1
|
Level
2
|
Level
3
|
Total
|
Level
1
|
Level
2
|
Level
3
|
Total
|
Level
1
|
Level
2
|
Level
3
|
Total
|
|
|
|
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
AIM quoted shares
|
4,207
|
368
|
-
|
4,575
|
4,135
|
356
|
-
|
4,491
|
3,851
|
309
|
-
|
4,160
|
Loan notes
|
-
|
-
|
508
|
508
|
-
|
-
|
508
|
508
|
-
|
-
|
508
|
508
|
Unquoted shares
|
-
|
-
|
75,608
|
75,608
|
-
|
-
|
87,169
|
87,169
|
-
|
-
|
87,253
|
87,253
|
|
4,207
|
368
|
76,116
|
80,691
|
4,135
|
356
|
87,677
|
92,168
|
3,851
|
309
|
87,761
|
91,921
|
10.
Risks and uncertainties
Under the Disclosure and
Transparency Directive, the Board is required in the Company's
half-yearly results to report on principal risks and uncertainties
facing the Company over the remainder of the financial
year.
The Board has concluded that the key
risks facing the Company over the remainder of the financial period
are as follows:
· investment risk associated with investing in small and
immature businesses;
· liquidity risk arising from investing mainly in unquoted
businesses; and
· failure to maintain approval as a VCT.
In all cases the Board is satisfied
with the Company's approach to these risks. As a VCT, the Company
is forced to have significant exposure to relatively immature
businesses. This risk is mitigated to some extent by holding a
well-diversified portfolio.
With a reasonably illiquid venture
capital investment portfolio, the Board ensures that it maintains
an appropriate proportion of its assets in cash and liquid
instruments.
The Company's compliance with the
VCT regulations is continually monitored by the Administrator and
Investment Manager, who regularly reports to the Board on the
current position. The Company also retains Philip Hare and
Associates LLP to provide regular reviews and advice in this area.
The Board considers that this approach reduces the risk of a breach
of the VCT regulations to a minimal level.
The Company has considerable
financial resources at the period end and holds a diversified
portfolio of investments. As a result, the Directors believe that
the Company is well placed to manage its business risks
successfully despite the current uncertain economic
outlook.
The Directors have concluded that
the Company has adequate resources to continue in operational
existence for the foreseeable future. Thus, they continue to adopt
the going concern basis of accounting in preparing the financial
statements.
11. The Directors confirm
that, to the best of their knowledge, the Half-Yearly financial
statements have been prepared in accordance with the "Statement:
Half-Yearly Financial Reports" issued by the UK Accounting
Standards Board as well as in accordance with FRS 104 Interim
Financial Reporting and the Half-Yearly financial report includes a
fair review of the information required by:
(a) DTR 4.2.7R of the
Disclosure and Transparency Rules, being an indication of important
events that have occurred during the first six months of the
current financial year and their impact on the condensed set of
financial statements, and a description of the principal risks and
uncertainties for the remaining six months of the year;
and
(b) DTR 4.2.8R of the Disclosure and
Transparency Rules, being related party transactions that have
taken place in the first six months of the current financial year
and that have materially affected the financial position or
performance of the entity during that period, and any changes in
the related party transactions described in the last Annual Report
that could do so.
12. The unaudited
financial statements set out herein do not constitute statutory
accounts within the meaning of Section 434 of the Companies Act
2006 and have not been delivered to the Registrar of Companies. The
figures for the period ended 31 March 2024 have been extracted from
the financial statements for that period, which have been delivered
to the Registrar of Companies; the Auditor's report on those
financial statements was unqualified.
13. Copies of the
unaudited Half-Yearly Report can be downloaded from
investors.moltenventures.com/investor-relations/vct
.